Wiley Matthew T.

Track

Insider profile

Wiley Matthew T.'s trades of Definium Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
261.38
Quantity 94,605
Value US$2,357,592
Transaction date
Proposed sale
Price
217.01
Quantity 10,557
Value US$1,426,654
Transaction date
Proposed sale
Price
0.69
Quantity 215
Value US$149
Transaction date
Proposed sale
Price
1.26
Quantity 244
Value US$308
Transaction date
Proposed sale
Price
2.63
Quantity 1,008
Value US$2,651
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-26 2026-06-25
PlS Planned sale
94,717 +19.2%
40.51
US$4,187,416 		94,717 +19.2% 40.51 US$4,187,416
2026-06-25 2026-06-25
PrS Proposed sale
94,605
261.38
US$2,357,592 		94,605 261.38 US$2,357,592
2024-10-03 2024-10-03
PrS Proposed sale
10,557
217.01
US$1,426,654 		10,557 217.01 US$1,426,654
2024-10-03 2024-10-03
PlS Planned sale
6,272 -24.8%
0.55
US$3,450 		6,272 -24.8% 0.55 US$3,450
2024-09-17 2024-09-16
PlS Planned sale
215 -5.1%
0.69
US$149 		215 -5.1% 0.69 US$149
2024-09-16 2024-09-16
PrS Proposed sale
215
0.69
US$149 		215 0.69 US$149
2024-06-18 2024-06-17
PlS Planned sale
244 -6.5%
1.26
US$308 		244 -6.5% 1.26 US$308
2024-06-17 2024-06-17
PrS Proposed sale
244
1.26
US$308 		244 1.26 US$308
2024-04-08 2024-04-04
PlS Planned sale
1,008 -25.2%
2.64
US$2,656 		1,008 -25.2% 2.64 US$2,656
2024-04-04 2024-04-04
PrS Proposed sale
1,008
2.63
US$2,651 		1,008 2.63 US$2,651
2019-03-06 2019-03-05
B Purchase
13,440 +26.9%
3.76
US$50,534 		13,440 +26.9% 3.76 US$50,534